Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant <i>Neisseria</i><i>gonorrhoeae</i> Strain

Monica M Lahra(Queensland Health), Irene Martín(Queensland Health), Walter Demczuk(Queensland Health), Amy V. Jennison(Queensland Health), Kenichi Lee(Queensland Health), Shu‐ichi Nakayama(Queensland Health), Brigitte Lefebvre(Queensland Health), Jean Longtin(Queensland Health), Alison Ward(Queensland Health), Michael R. Mulvey(Queensland Health), Teodora Wi(Queensland Health), Makoto Ohnishi(Queensland Health), David M. Whiley(Queensland Health)
Emerging infectious diseases
March 6, 2018
Cited by 237Open Access
Full Text

Abstract

Ceftriaxone remains a first-line treatment for patients infected by Neisseria gonorrhoeae in most settings. We investigated the possible spread of a ceftriaxone-resistant FC428 N. gonorrhoeae clone in Japan after recent isolation of similar strains in Denmark (GK124) and Canada (47707). We report 2 instances of the FC428 clone in Australia in heterosexual men traveling from Asia. Our bioinformatic analyses included core single-nucleotide variation phylogeny and in silico molecular typing; phylogenetic analysis showed close genetic relatedness among all 5 isolates. Results showed multilocus sequence type 1903; N. gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) 233; and harboring of mosaic penA allele encoding alterations A311V and T483S (penA-60.001), associated with ceftriaxone resistance. Our results provide further evidence of international transmission of ceftriaxone-resistant N. gonorrhoeae. We recommend increasing awareness of international spread of this drug-resistant strain, strengthening surveillance to include identifying treatment failures and contacts, and strengthening international sharing of data.


Related Papers

No related papers found

Powered by citation graph analysis